Developing Standardized Corticosteroid Treatment for Duchenne Muscular Dystrophy.
Document Type
Journal Article
Publication Date
7-1-2017
Journal
Contemporary Clinical Trials
Volume
58
Inclusive Pages
34-39
DOI
10.1016/j.cct.2017.04.008
Keywords
Child; Child, Preschool; Disability Evaluation; Double-Blind Method; Drug Administration Schedule; Heart Function Tests; Humans; Immunosuppressive Agents; Male; Muscle Strength; Muscular Dystrophy, Duchenne; Patient Satisfaction; Prednisone; Pregnenediones; Range of Motion, Articular; Research Design; Vital Capacity
APA Citation
Guglieri, M., Bushby, K., McDermott, M., Hart, K., Tawil, R., Martens, W., Herr, B., McColl, E., Wilkinson, J., Kirschner, J., King, W., Eagle, M., Brown, M., Willis, T., Hirtz, D., Shieh, P., Straub, V., Childs, A., Ciafaloni, E., Butterfield, R., Horrocks, I., Spinty, S., Flanigan, K., Kuntz, N., Baranello, G., Roper, H., Morrison, L., Mah, J., Manzur, A., McDonald, C., Schara, U., von der Hagen, M., Barohn, R., Campbell, C., Darras, B., Finkel, R., Vita, G., Hughes, I., Mongini, T., Pegoraro, E., Wicklund, M., Wilichowski, E., Bryan Burnette, W., Howard, J., McMillan, H., Thangarajh, M., & Griggs, R. (2017). Developing Standardized Corticosteroid Treatment for Duchenne Muscular Dystrophy.. Contemporary Clinical Trials, 58 (). http://dx.doi.org/10.1016/j.cct.2017.04.008
Peer Reviewed
1